FITC anti-mouse F4/80 Antibody

Pricing & Availability
Clone
BM8 (See other available formats)
Regulatory Status
RUO
Other Names
EMR1, Ly71
Isotype
Rat IgG2a, κ
Ave. Rating
Submit a Review
Product Citations
publications
BM8_FITC_090707
Thioglycolate-elicited Balb/c mouse peritoneal macrophages stained with BM8 FITC
  • BM8_FITC_090707
    Thioglycolate-elicited Balb/c mouse peritoneal macrophages stained with BM8 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
123107 50 µg $65
Check Availability


Need larger quantities of this item?
Request Bulk Quote
123108 500 µg $185
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

F4/80 is a 160 kD glycoprotein. It is characterized as a member of the epidermal growth factor (EGF)-transmembrane 7 (TM7) family. F4/80, also known as EMR1 or Ly71, has been widely used as a murine macrophage marker, which is expressed on the majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen (but not on the macrophages located in T cell areas of the spleen, lymph node and Peyer's patch), Kuffer cells, Langerhans cells, and bone marrow stromal cells. F4/80 has also been shown on a subset of dendritic cells. The biological ligand of F4/80 has not been identified, but it has been reported that F4/80 is required for induction of CD8+ T cells-mediated peripheral tolerance.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Murine macrophages
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections1,2 and formalin-fixed paraffin-embedded sections6,7, Western blotting, and spatial biology (IBEX)12,13.

Application References

(PubMed link indicates BioLegend citation)
  1. Schaller E, et al. 2002. Mol. Cell. Biol. 22:8035. (IHC)
  2. Stevceva L, et al. 2001. BMC Clin Pathol. 1:3. (IHC)
  3. Kobayashi M, et al.2008. J. Leukoc. Biol. 83:1354. PubMed
  4. Poeckel D, et al. 2009. J. Biol Chem. 284:21077. PubMed
  5. Glass AM, et al. 2013. J. Immunol. 190:4830. PubMed
  6. Koehm S, et al. 2007. J. Allergy Clin. Immunol. 120:570. (IHC)
  7. Rankin AL, et al. 2010. J. Immunol. 184:1526. (IHC)
  8. Sasi SP, et al. 2014. J Biol Chem. 289:14178. PubMed
  9. Thakus VS, et al. 2014. Toxicol Lett. 230:322. PubMed
  10. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
  11. Hirakawa H, et al. 2015. PLoS One. 10:119360. PubMed
  12. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  13. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Jiang L, et al. 2013. Mol Immunol. 54:14. PubMed
  2. Liu K, et al. 2021. Cell Metabolism. 33(3):666-675.e4. PubMed
  3. Liu J, et al. 2019. Immunity. 50:600. PubMed
  4. Xiong Y, et al. 2020. J Nanobiotechnology. 18:66. PubMed
  5. Wang L, et al. 2008. Cancer Res. 68:5639. PubMed
  6. Jiang Z, et al. 2021. J Clin Invest. 131: . PubMed
  7. Vasanthakumar A, et al. 2020. Nature. 579:581. PubMed
  8. Liang J, et al. 2021. Cancer Manag Res. 13:6977. PubMed
  9. Li F, et al. 2022. Mediators Inflamm. 2022:5782922. PubMed
  10. Wang HH, et al. 2022. J Biomed Sci. 29:36. PubMed
  11. Zheng M, et al. 2016. Sci Rep. 6:28729. PubMed
  12. Marcil A, et al. 2008. Infect Immun. 76:4345. PubMed
  13. Kimura H, et al. 2017. J Immunol. 10.4049/jimmunol.1601798. PubMed
  14. Chen Y, et al. 2018. EBioMedicine. 32:31. PubMed
  15. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  16. Barry KC, et al. 2018. Nat Med. 24:1178. PubMed
  17. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  18. Hsu SPC, et al. 2020. J Neurooncol. 146:417. PubMed
  19. Morgan PK, et al. 2021. J Biol Chem. 297:101341. PubMed
  20. Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
  21. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  22. Mouton AJ, et al. 2018. Basic Res Cardiol. 113:26:00. PubMed
  23. Lee Y, et al. 2017. PLoS One.. 10.1371/journal.pone.0183028. PubMed
  24. Stubelius A, et al. 2017. Immunobiology. 10.1016/j.imbio.2017.05.007. PubMed
  25. Zhang L, et al. 2022. Acta Pharm Sin B. 12:3427. PubMed
  26. Zhou X, et al. 2022. Front Pharmacol. 13:887263. PubMed
  27. Chauhan A, et al. 2020. Nat Commun. 11:1939. PubMed
  28. Rogic A, et al. 2021. Nat Commun. 12:6889. PubMed
  29. Gu T, et al. 2021. Front Immunol. 11:621441. PubMed
  30. Ohtsuki T, et al. 2016. J Virol. 90: 300 - 307. PubMed
  31. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  32. Qiu X, et al. 2019. Theranostics. 9:2618. PubMed
  33. Brunner JS, et al. 2020. Nat Commun. 0.757638889. PubMed
  34. Alvarez M, et al. 2020. Cancers (Basel). 12:. PubMed
  35. Shi S, et al. 2020. Clin Cancer Res. 26:5990. PubMed
  36. Wang Y, et al. 2020. J Immunol. 205:2905. PubMed
  37. Zhou HF, et al. 2022. Front Pharmacol. 13:778755. PubMed
  38. Xiong A, et al. 2022. EBioMedicine. 83:104239. PubMed
  39. Royzman D, et al. 2022. Front Immunol. 13:1012647. PubMed
  40. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  41. An YA et al. 2017. eLife. 6 pii: e24071. PubMed
  42. Wang Y, et al. 2022. Front Immunol. 13:767630. PubMed
  43. Kedage V, et al. 2022. MAbs. 14:2040083. PubMed
  44. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  45. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  46. Dichtl S, et al. 2021. Sci Adv. 7: . PubMed
  47. Klopfenstein N, et al. 2021. PLoS Pathog. 17:e1009387. PubMed
  48. Xiao Z, et al. 2015. Cancer Lett. 360:302. PubMed
  49. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  50. Ratitong B, et al. 2021. Cell Reports. 35(7):109139. PubMed
  51. Nakazeki F, et al. 2018. Sci Rep. 8:8553. PubMed
  52. Barger SR, et al. 2019. Nat Commun. 10:1249. PubMed
  53. Zhang S, et al. 2019. Mol Med Rep. 19:5377. PubMed
  54. Dan H, et al. 2020. Mol Oncol. 14:795. PubMed
  55. García-Bonilla M, et al. 2020. Stem Cell Res Ther. 11:121. PubMed
  56. Niss K, et al. 2020. Cell Reports. 31(11):107763. PubMed
  57. Wang F, et al. 2021. Cell Mol Gastroenterol Hepatol. 13:257. PubMed
  58. Xiao P, et al. 2021. JCI Insight. 6:. PubMed
  59. Zheng Y, et al. 2022. Front Pharmacol. 12:816032. PubMed
  60. Jing L, et al. 2022. Front Immunol. 13:864995. PubMed
  61. Zhang X, et al. 2021. Front Immunol. 12:680068. PubMed
  62. Zhang Y, et al. 2022. Nat Commun. 13:4553. PubMed
  63. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  64. Zhao X, et al. 2014. J Biol Chem. 289:30052. PubMed
  65. Suo J, et al. 2014. J Leukoc Biol. 96:133. PubMed
  66. Bignami F, et al. 2017. Acta Ophthalmol. 95:e641. PubMed
  67. Yu H, et al. 2022. J Orthop Surg Res. 17:232. PubMed
  68. Feng T, et al. 2022. Nat Commun. 13:5208. PubMed
  69. Gu Y, et al. 2021. Cell Res. Online ahead of print. PubMed
  70. Kornstädt L, et al. 2021. Front Immunol. 11:607048. PubMed
  71. Odkhuu E, et al. 2014. Innate Immunity. 21:194. PubMed
  72. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  73. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  74. Omori S, et al. 2021. Cell Reports. 34(6):108734. PubMed
  75. DeVito NC, et al. 2021. Cell Reports. 35(5):109071. PubMed
  76. Proto JD et al. 2018. Immunity. 49(4):666-677 . PubMed
  77. Wu W, et al. 2018. J Am Soc Nephrol. 29:168. PubMed
  78. Niemann J, et al. 2019. Nat Commun. 10:3236. PubMed
  79. Rashidi M, et al. 2019. J Immunol. 203:736. PubMed
  80. Duan RN, et al. 2021. J Neuroinflammation. 18:145. PubMed
  81. Wang J, et al. 2021. Nat Commun. 12:6198. PubMed
  82. Wang Y, et al. 2021. EMBO J. 40:e105543. PubMed
  83. Barsoumian HB, et al. 2020. J Immunother Cancer. 8:00. PubMed
  84. Vettorazzi S, et al. 2015. Nat Commun. 6: 7796. PubMed
  85. Miki Y, et al. 2013. J Exp Med. 210:1217. PubMed
  86. Linde N, et al. 2012. PLoS One. 7:e40058. PubMed
  87. Moon H, et al. 2020. Nat Commun. 4.270138889. PubMed
  88. Wan X, et al. 2018. Nature. 560:107. PubMed
  89. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  90. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  91. Yu Y, et al. 2018. Mol Med Rep. 17:8212. PubMed
  92. Irie Y, et al. 2017. J Neuroimmune Pharmacol. 10.1007/s11481-017-9757-2. PubMed
  93. Wang H, et al. 2022. J Nanobiotechnology. 20:445. PubMed
  94. Wang Y, et al. 2022. Cell Death Dis. 13:748. PubMed
  95. Wu Y, et al. 2021. PLoS Negl Trop Dis. 15:e0010050. PubMed
  96. Lewis EL, et al. 2021. Front Immunol. 12:741518. PubMed
  97. Cai C, et al. 2021. Sci Rep. 11:13386. PubMed
  98. Artz A, Butz S, Vestweber D 2016. Am J Physiol Renal Physiol. 311: F176 - F181. PubMed
  99. Abe M, et al. 2020. Clin Exp Immunol. 303:199. PubMed
  100. Matsumoto K, et al. 2017. PLoS One. 12(6):e0175406. PubMed
  101. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  102. Martínez‐López M et al. 2019. Immunity. 50(2):446-461 . PubMed
  103. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  104. Kasahara D, et al. 2012. J Immunol. 188:4558. PubMed
  105. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  106. Machácek T, et al. 2022. PLoS Pathog. 18:e1010302. PubMed
  107. Qin W, et al. 2021. FASEB J. 35:e21599. PubMed
  108. Zhang Q, et al. 2022. Nat Commun. 13:2406. PubMed
  109. Koikawa K, et al. 2021. Cell. 184(18):4753-4771.e27. PubMed
  110. Parayath NN, et al. 2020. Nat Commun. 4.680555556. PubMed
  111. Arce-Cerezo A, et al. 2015. Sci Rep. 5: 1448. PubMed
  112. Torres I, et al. 2014. Infect Immun . 82:4689. PubMed
  113. Deng G, et al. 2010. J Immunol. 184:7154. PubMed
  114. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  115. Stifter SA, et al. 2019. Cell Rep. 29:3539. PubMed
  116. Tomay F, et al. 2019. J Transl Med. 17:237. PubMed
  117. Zheng X, et al. 2018. J Clin Invest. 128:2104. PubMed
  118. Fan Q, et al. 2021. Bioact Mater. 6:4014. PubMed
  119. Patankar Y, et al. 2015. Am J Physiol Lung Cell Mol Physiol. 309: L902 - L913. PubMed
  120. Uematsu T, et al. 2016. Sci Rep. 6:37815. PubMed
  121. Taye B, et al. 2017. BMC Genomics . 10.1186/s12864-017-3803-6. PubMed
  122. Wang Y et al. 2017. Cell. 171(2):331-345 . PubMed
  123. Subramanian K, et al. 2019. Nat Microbiol. 4:62. PubMed
  124. Hou PP, et al. 2020. Molecular Cell. 78(6):1192-1206.e10. PubMed
  125. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  126. Honda H, et al. 2014. J Leukoc Biol. 96:1087. PubMed
  127. Drori A, et al. 2014. PLoS One. 9:110942. PubMed
  128. Quick M, et al. 2012. Am J Physiol Regul Integr Comp Physiol. 303:580. PubMed
  129. Lu SW, et al. 2020. Nat Commun. 3.660416667. PubMed
  130. Fukushima K, et al. 2020. Immunity. 52(3):542-556. PubMed
  131. Li YT, et al. 2019. Elife. 8:e47642. PubMed
  132. Baomei Wang et al. 2019. Cell reports. 26(6):1614-1626 . PubMed
  133. Du H, et al. 2017. Nat Commun. 10.1038/s41467-017-00522-7. PubMed
  134. Nenasheva T, et al. 2017. PLoS One. 12(6):e0178983. PubMed
  135. Howard ZM, et al. 2022. JCI Insight. 7:. PubMed
  136. Miki Y, et al. 2022. JCI Insight. 7:. PubMed
  137. Anderson-Baucum E, et al. 2021. Cell Metab. 33:1883. PubMed
  138. Raoof R, et al. 2021. J Neurosci. 41:8249. PubMed
  139. Wang X, et al. 2022. J Biol Chem. 298:101561. PubMed
  140. Yuan M, et al. 2022. Oxid Med Cell Longev. 2022:5479491. PubMed
  141. Chen Z, et al. 2016. PLoS One. 11: 0146681. PubMed
  142. Mothes B, et al. 2016. PLoS One. 11: 0159310. PubMed
  143. Yuan Y, et al. 2020. Front Physiol. 0.967361111. PubMed
  144. Bordas M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  145. Lv JJ, et al. 2021. Front Cell Dev Biol. 8:609090. PubMed
  146. Yan T, et al. 2021. Toxicological Sciences. 181(2):273-284. PubMed
  147. Dongsheng Z, et al. 2017. Inflammation. 10.1007/s10753-017-0619-0. PubMed
  148. Di G, et al. 2017. Invest Ophthalmol Vis Sci. 10.1167/iovs.17-21506. PubMed
  149. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  150. Osorio K, et al. 2011. J Cell Biol. 193:235. PubMed
  151. Deng Q, et al. 2021. Gut Microbes. 13:1. PubMed
  152. Glasenapp A, et al. 2021. Circ Res. 129:369. PubMed
  153. Zheng X, et al. 2020. Int J Cancer. 146:1730. PubMed
  154. Vaibhav K, et al. 2020. Sci Adv. 6:eaax8847. PubMed
  155. Zhou T, et al. 2021. Bioact Mater. 0.734027778. PubMed
  156. van Aalst S, et al. 2017. Vaccine. 10.1016/j.vaccine.2017.02.005. PubMed
  157. Meunier I, et al. 2015. PLoS One. 10: 0138055. PubMed
  158. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  159. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  160. Lu Q, et al. 2022. Biomed Res Int. 2022:9427076. PubMed
  161. Nam J, et al. 2021. Adv Ther (Weinh). 4:. PubMed
  162. Howard ZM, et al. 2021. Am J Pathol. 191:730. PubMed
  163. Li Y, et al. 2020. Theranostics. 10:2897. PubMed
  164. Zhao H, et al. 2022. Commun Biol. 5:74. PubMed
  165. Lee SA, et al. 2021. Cells. 10:. PubMed
  166. Elias I, et al. 2012. Diabetes. 61:1801. PubMed
  167. Schaffert S, et al. 2015. J Immunol. 195: 1470-1479. PubMed
  168. Porrello A, et al. 2018. Nat Commun. 9:1988. PubMed
  169. Lancaster GI et al. 2018. Cell metabolism. 27(5):1096-1110 . PubMed
  170. Lang JF et al. 2019. Nat Commun. 10(1):3415 . PubMed
  171. Yoshida H, et al. 2019. Cell. 176:897. PubMed
  172. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  173. Vazquez-Lombardi R, et al. 2017. Nat Commun. 8:15373. PubMed
  174. Morein D, et al. 2021. Cells. 10: . PubMed
  175. Sakurai Y, et al. 2021. Pharmaceutics. 13:. PubMed
  176. Zhang F, et al. 2021. J Immunol Res. 2021:5521051. PubMed
  177. Liu C, et al. 2022. Cell Death Discov. 8:269. PubMed
  178. Gautam S, et al. 2020. Am J Physiol Lung Cell Mol Physiol. 319:L661. PubMed
  179. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  180. Simoni L, et al. 2020. Cell Rep. 33:108330. PubMed
  181. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  182. Kwon H, Kim S 2016. Cell Death Dis. 7:22285. PubMed
  183. Zhang J, et al. 2020. J Cell Mol Med. 24:4547. PubMed
  184. Rodriguez-Tirado C, et al. 2022. Cancers (Basel). 14:. PubMed
  185. Fite BZ, et al. 2021. Sci Rep. 11:927. PubMed
  186. Bringmann G, et al. 2013. Antimicrob Agents Chemother. 57:3003. PubMed
  187. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  188. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  189. Albaghdadi AJH, et al. 2019. Sci Rep. 9:6528. PubMed
  190. Li B et al. 2019. Cell reports. 26(10):2720-2737 . PubMed
  191. Li A, et al. 2018. Cancer Lett. 431:54. PubMed
  192. Kurelac I, et al. 2019. J Clin Med. 1.85. PubMed
  193. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  194. Bhatia S, et al. 2019. Cancer Res. 79:2722. PubMed
  195. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  196. Caetano MS, et al. 2019. Clin Cancer Res. 25:7576. PubMed
  197. Guo Y, et al. 2021. Nat Immunol. 22:746. PubMed
  198. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
  199. Uematsu T, et al. 2015. Sci Rep. 5: 17577. PubMed
  200. Wegiel B, et al. 2014. Cell Death Dis. 5:1139. PubMed
  201. Richardson M, et al. 2014. PLoS Negl Trop Dis. 8:2825. PubMed
  202. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  203. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  204. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  205. Zhong J, et al. 2021. Commun Biol. 4:865. PubMed
  206. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  207. Yang F, et al. 2021. Nat Commun. 12:3424. PubMed
RRID
AB_893500 (BioLegend Cat. No. 123107)
AB_893502 (BioLegend Cat. No. 123108)

Antigen Details

Structure
EGF-TM7 family member, 160 kD glycoprotein
Distribution

Majority of tissue macrophages including peritoneal macrophages, macrophages in lung, gut, thymus and red pulp of spleen, Kuffer cells, Langerhans cells, bone marrow stromal cells, and a subset of dendritic cells

Function
Induction of immunological tolerance
Cell Type
Dendritic cells, Langerhans cells, Macrophages, Tregs
Biology Area
Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
Antigen References

1. Austy JM and Gordon S. 1981. Eur. J. Immunol. 11:805.
2. Hume DA, et al. 1983. J. Exp. Med. 158:1522.
3. Ruedl C, et al. 1996. Eur. J. Immunol. 26:1801.
4. McKnight AJ, et al. 1996. J. Biol. Chem. 271:486.
5. Lin HH, et al. 2005. J. Exp. Med. 201:1615.

Gene ID
13733 View all products for this Gene ID
UniProt
View information about F4/80 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 10/25/2013

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • Brilliant Violet 605™ anti-mouse F4/80

  • Purified anti-mouse F4/80

  • Biotin anti-mouse F4/80

  • FITC anti-mouse F4/80

  • PE anti-mouse F4/80

  • PE/Cyanine5 anti-mouse F4/80

  • PE/Cyanine7 anti-mouse F4/80

  • APC anti-mouse F4/80

  • APC/Cyanine7 anti-mouse F4/80

  • Alexa Fluor® 488 anti-mouse F4/80

  • Alexa Fluor® 647 anti-mouse F4/80

  • Pacific Blue™ anti-mouse F4/80

  • PerCP anti-mouse F4/80

  • PerCP/Cyanine5.5 anti-mouse F4/80

  • Alexa Fluor® 700 anti-mouse F4/80

  • Brilliant Violet 421™ anti-mouse F4/80

  • Brilliant Violet 510™ anti-mouse F4/80

  • Alexa Fluor® 594 anti-mouse F4/80

  • Brilliant Violet 785™ anti-mouse F4/80

  • Purified anti-mouse F4/80 (Maxpar® Ready)

  • PE/Dazzle™ 594 anti-mouse F4/80

  • Brilliant Violet 650™ anti-mouse F4/80

  • Brilliant Violet 711™ anti-mouse F4/80

  • APC/Fire™ 750 anti-mouse F4/80

  • TotalSeq™-A0114 anti-mouse F4/80

  • TotalSeq™-B0114 anti-mouse F4/80

  • TotalSeq™-C0114 anti-mouse F4/80

  • Spark YG™ 570 anti-mouse F4/80

  • KIRAVIA Blue 520™ anti-mouse F4/80

  • Ultra-LEAF™ Purified anti-mouse F4/80

  • APC/Fire™ 810 anti-mouse F4/80

  • Spark NIR™ 685 anti-mouse F4/80

ProductsHere

Login/Register
Remember me
Forgot your password? Reset Password
Request an Account